Common use of Designation and Principal Amount Clause in Contracts

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.900% Notes due 2062,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

AutoNDA by SimpleDocs

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.700% Notes due 20622029,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2029 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle IX herein.

Appears in 1 contract

Samples: BlackRock Inc.

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9003.700% Notes due 20622052,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2052 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2052 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9003.550% Notes due 20622042,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2042 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2042 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9005.110% Notes due 20622043,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2043 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.750% Notes due 20622033,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2033 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9005.75% Notes due 2062,” March 15, 2018”, which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Burlington Northern Santa Fe Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.650% Notes due 20622025,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2025 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.650% Notes due 20622030,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2030 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.450% Notes due 20622028,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2028 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9005.300% Notes due 20622053,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2053 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9003.250% Notes due 2062February 1, 2023,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 2.4 of the Base Indenture.

Appears in 1 contract

Samples: KOHLS Corp

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.000% Notes NOTES due 2062,” November 1, 2021”, which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 2.4 of the Base Indenture.

Appears in 1 contract

Samples: KOHLS Corp

AutoNDA by SimpleDocs

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9002.950% Notes due 20622032,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2032 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2032 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9003.250% Notes due 20622042,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2042 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2042 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Supplemental Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9002.000% Notes due 20622022,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2022 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2022 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Supplemental Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.750% Notes due 2062December 15, 2023,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 2.4 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (KOHLS Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.450% Notes due 20622026,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the 2026 Notes to be issued shall be as on the date hereof is set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base IndentureArticle Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9004.700% Notes due 2062,” October 1, 2019”, which is not limited in aggregate principal amount. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Fourth Supplemental Indenture (Burlington Northern Santa Fe Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “3.9000.875% Notes due 20622017,” which is not limited in aggregate principal amount. The aggregate principal amount of 2062 2017 Notes to be issued shall be as set forth in any Company Order for the authentication and delivery of the 2062 2017 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Supplemental Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series Series of Securities under the Indenture, designated as the “3.9002.500% Senior Notes due 2062,” 2030”, which is not limited in aggregate principal amount. The Notes shall constitute a separate Series of Securities under the Indenture. The aggregate principal amount of 2062 the Notes to be issued shall be as set forth in any Company Order Corporation order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 2.1 of the Base Indenture.

Appears in 1 contract

Samples: Martin Marietta Materials Inc

Time is Money Join Law Insider Premium to draft better contracts faster.